The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.
Continued here:
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems